AAAAAA

   
Results: 1-25 | 26-33 |
Results: 26-33/33
IDENTIFICATION AND ANTIMICROBIAL RESISTANCE PATTERNS OF CLINICAL ISOLATES OF CLOSTRIDIUM-CLOSTRIDIOFORME, CLOSTRIDIUM-INNOCUUM AND CLOSTRIDIUM-RAMOSUM COMPARED WITH THOSE OF CLINICAL ISOLATES OF CLOSTRIDIUM-PERFRINGENS
Authors: ALEXANDER CJ CITRON DM BRAZIER JS GOLDSTEIN EJC
Citation: Cj. Alexander et al., IDENTIFICATION AND ANTIMICROBIAL RESISTANCE PATTERNS OF CLINICAL ISOLATES OF CLOSTRIDIUM-CLOSTRIDIOFORME, CLOSTRIDIUM-INNOCUUM AND CLOSTRIDIUM-RAMOSUM COMPARED WITH THOSE OF CLINICAL ISOLATES OF CLOSTRIDIUM-PERFRINGENS, Journal of clinical microbiology, 33(12), 1995, pp. 3209-3215
COMPARATIVE IN-VITRO ACTIVITIES OF AZITHROMYCIN, BAY-Y-3118, LEVOFLOXACIN, SPARFLOXACIN, AND 11 OTHER ORAL ANTIMICROBIAL AGENTS AGAINST 194AEROBIC AND ANAEROBIC BITE WOUND ISOLATES
Authors: GOLDSTEIN EJC NESBIT CA CITRON DM
Citation: Ejc. Goldstein et al., COMPARATIVE IN-VITRO ACTIVITIES OF AZITHROMYCIN, BAY-Y-3118, LEVOFLOXACIN, SPARFLOXACIN, AND 11 OTHER ORAL ANTIMICROBIAL AGENTS AGAINST 194AEROBIC AND ANAEROBIC BITE WOUND ISOLATES, Antimicrobial agents and chemotherapy, 39(5), 1995, pp. 1097-1100
CHARACTERIZATION OF A BETA-LACTAMASE FROM CLOSTRIDIUM CLOSTRIDIOFORME
Authors: APPELBAUM PC SPANGLER SK PANKUCH GA PHILIPPON A JACOBS MR SHIMAN R GOLDSTEIN EJC CITRON DM
Citation: Pc. Appelbaum et al., CHARACTERIZATION OF A BETA-LACTAMASE FROM CLOSTRIDIUM CLOSTRIDIOFORME, Journal of antimicrobial chemotherapy, 33(1), 1994, pp. 33-40
EMPYEMA DUE TO BACTEROIDES-GRACILIS - CASE-REPORT AND INVITRO SUSCEPTIBILITIES TO 8 ANTIMICROBIAL AGENTS
Authors: LEE D GOLDSTEIN EJC CITRON DM ROSS S
Citation: D. Lee et al., EMPYEMA DUE TO BACTEROIDES-GRACILIS - CASE-REPORT AND INVITRO SUSCEPTIBILITIES TO 8 ANTIMICROBIAL AGENTS, Clinical infectious diseases, 16, 1993, pp. 190000263-190000265
HOW FAR SHOULD A CLINICAL LABORATORY GO IN IDENTIFYING ANAEROBIC ISOLATES, AND WHO SHOULD PAY
Authors: CITRON DM APPELBAUM PC
Citation: Dm. Citron et Pc. Appelbaum, HOW FAR SHOULD A CLINICAL LABORATORY GO IN IDENTIFYING ANAEROBIC ISOLATES, AND WHO SHOULD PAY, Clinical infectious diseases, 16, 1993, pp. 190000435-190000438
COMMENTARY - ANAEROBIC INFECTION FOLLOWING ANIMAL BITES
Authors: GOLDSTEIN EJC CITRON DM
Citation: Ejc. Goldstein et Dm. Citron, COMMENTARY - ANAEROBIC INFECTION FOLLOWING ANIMAL BITES, Infectious diseases in clinical practice, 2(5), 1993, pp. 358-359
METHODS FOR TESTING THE SUSCEPTIBILITY OF ANAEROBIC-BACTERIA TO 2 FLUOROQUINOLONE COMPOUNDS, PD-131628 AND CLINAFLOXACIN
Authors: BARRY AL FUCHS PC CITRON DM ALLEN SD WEXLER HM
Citation: Al. Barry et al., METHODS FOR TESTING THE SUSCEPTIBILITY OF ANAEROBIC-BACTERIA TO 2 FLUOROQUINOLONE COMPOUNDS, PD-131628 AND CLINAFLOXACIN, Journal of antimicrobial chemotherapy, 31(6), 1993, pp. 893-900
COMPARATIVE SUSCEPTIBILITIES OF 173 AEROBIC AND ANAEROBIC BITE WOUND ISOLATES TO SPARFLOXACIN, TEMAFLOXACIN, CLARITHROMYCIN, AND OLDER AGENTS
Authors: GOLDSTEIN EJC CITRON DM
Citation: Ejc. Goldstein et Dm. Citron, COMPARATIVE SUSCEPTIBILITIES OF 173 AEROBIC AND ANAEROBIC BITE WOUND ISOLATES TO SPARFLOXACIN, TEMAFLOXACIN, CLARITHROMYCIN, AND OLDER AGENTS, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 1150-1153
Risultati: 1-25 | 26-33 |